Product Specifications Product : BPC-157 & TB-500 40mg Research Blend Components : BPC-157, TB-500 Total Content : Approximately 40mg (21.99 mg BPC-157 + 19.59 mg TB-500) Concentration : BPC-157 7.33 mg/mL, TB-500 6.53 mg/mL Fill Volume : 3 mL Batch Number : BP1701FSR Format : Pre-filled research pen/device Appearance : Clear, colorless solution (subject to verification) Packaging : Sealed research kit with information sheet Purity & Quality Standards At Alluvi Solutions, purity and consistency are paramount
Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy
The TB-500-exposed tissues also featured more uniform spacing between fibrils, suggesting a more orderly matrix that may support stronger tissue formation
Product Details Available sizes: 600 mg, 1200 mg, and 1500 mg Form: Lyophilized powder Testing: Independent third-party testing COA: Available by lot Origin: Manufactured in the USA Packaging: Sealed vial Storage: Refrigerate between 2C and 8C
